Here is the latest shareholding Pattern of SUVEN PHARMACEUTICALS. For more details, see the SUVEN PHARMACEUTICALS financial fact sheet and SUVEN PHARMACEUTICALS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 60.00 | 60.00 | 60.00 | 60.00 | 60.00 | 9.90 | 9.90 | 0.00 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 50.10 | 50.10 | 50.10 | |
Total Promoters | % | 60.00 | 60.00 | 60.00 | 60.00 | 60.00 | 60.00 | 60.00 | 50.10 | |
Mutual Funds | % | 6.32 | 8.28 | 8.97 | 8.56 | 9.12 | 12.15 | 13.40 | 15.26 | |
Financial institution/Banks/Insurance | % | 0.00 | 2.24 | 2.23 | 2.26 | 0.11 | 1.39 | 1.89 | 1.57 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | |
FII | % | 8.49 | 7.58 | 8.10 | 9.47 | 9.50 | 10.01 | 10.14 | 9.54 | |
Other | % | 0.64 | 0.35 | 0.16 | 0.61 | 1.39 | 0.60 | 0.65 | 0.41 | |
Total Institution | % | 15.45 | 18.45 | 19.46 | 20.90 | 20.13 | 24.16 | 26.09 | 26.79 | |
Bodies Corporate | % | 1.94 | 1.89 | 1.72 | 1.72 | 2.55 | 2.38 | 1.43 | 11.10 | |
Individuals | % | 16.86 | 14.69 | 14.01 | 12.76 | 12.80 | 11.76 | 10.87 | 10.51 | |
NRIs/OCBs | % | 3.53 | 3.55 | 3.46 | 3.33 | 3.29 | 1.03 | 1.00 | 0.97 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 2.22 | 1.42 | 1.34 | 1.29 | 1.23 | 0.67 | 0.62 | 0.52 | |
Total Non-Institution | % | 24.55 | 21.55 | 20.53 | 19.10 | 19.87 | 15.84 | 13.92 | 23.10 | |
Total Public | % | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 50.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
Indian share markets continued the momentum as the session progressed and ended the higher.